Member Societies

• All
• 298
• 299
• 300

Symposium 01 (KASL) : Distinguished Research of 2021 in Liver Disease Korean

Date / Time	298,
Channel
Speakers	08:30-08:52	Viral hepatitis
	08:52-09:14	Alcoholic and nonalcoholic liver disease
	09:14-09:36	Liver cirrhosis and complications
	09:36-09:58	Hepatocellular carcinoma

Memorial Lecture (KASL) : Chung Yong Kim Memorial Lecture Korean

Date / Time	298,
Channel
Speaker	10:15-10:45	Beyond the best with humanity and creativity

Symposium 03 (KASL) : AI Application in Future Hepatology Korean

Date / Time	298,
Channel
Speakers	12:25-12:47	The application of texture quantification in hepatocellular carcinoma using CT and MRI
	12:47-13:09	Next generation diagnostic pathology: Artificial intelligence-powered diagnosis and biomarker analysis
	13:09-13:31	Utilization of digital healthcare big data
	13:31-13:53	Profiling based identification and application of non-coding RNAs as biomarker for hepatocellular carcinoma

Symposium 07 (KASL) : Clinical Decision in Chronic Liver Diseases Korean

Date / Time	298,
Channel
Speakers	14:10-14:32	The assessment of NAFLD using diagnostic algorithm
	14:32-14:54	The sequential application of systemic chemotherapy in advanced HCC
	14:54-15:16	The treatment of nonselective beta blocker to patients with varices: (Who, When, and Which drug)
	15:16-15:38	The selection of proper anti-viral agents to patients with CHB in each condition

Symposium 11 (KASL) : Liver Disease and Vaccination Korean

Date / Time	298,
Channel
Speakers	15:55-16:17	The present and future of therapeutic vaccine for viral hepatitis B
	16:17-16:39	The present and future of therapeutic or preventative vaccine for viral hepatitis C
	16:39-17:01	COVID-19 vaccination in patients with chronic liver disease
	17:01-17:23	Vaccination strategy for patients with chronic liver disease and liver transplantation

Symposium 04 (KCHUGR) : Prevention and Management of Post-procedural GI Complication: What’s New? English

Date / Time	298,
Channel
Speakers	12:25-12:47	The role of endoscopic management in afferent loop syndrome
	12:47-13:09	Novel approach for prevention of post-ESD bleeding
	13:09-13:31	Optimal use of the over-the-scope clip for treatment of GI complication
	13:31-13:53	New modalities for treatment of post-operative anastomotic leak

Symposium 08 (KCHUGR) : Inflammation and Aging of Upper GI Tract English

Date / Time	298,
Channel
Speakers	14:10-14:32	Physiologic and pathologic changes of GI tract of the elderly
	14:32-14:54	Atrophic gastritis and other chronic inflammation and gastric carcinogenesis
	14:54-15:16	Antithrombotic-induced upper GI injury
	15:16-15:38	NSAIDs-induced upper GI injury

Symposium 12 (Gender-specific Medicine) : Gender-Specific Medicine in GI Cancers and IBD English & Korean

Date / Time	298,
Channel
Speakers	15:55-16:17	Gender perspective in esophageal cancer
	16:17-16:39	Sex differences in colon cancer: Epidemiology, genetics and therapy
	16:39-17:01	Sex differences in the risk factors for hepatocellular carcinoma in Korea
	17:01-17:23	Sex matters: Impact on pathogenesis, presentation and treatment of inflammatory bowel disease

Symposium 02 (KSNM) : Constipation: What’s New in 2021? English

Date / Time	298,
Channel
Speakers	08:30-08:50	Epidemiology
	08:50-09:10	Diagnostic approach
	09:10-09:30	Novel pharmacologic treatment
	09:30-09:50	Non-medical treatment for refractory constipation
	09:50-10:00	Discussion

ANMA-KSNM Joint Symposium (KSNM) : Dyspepsia: What's New in 2021? English

Date / Time	298,
Channel
Speakers	10:15-10:35	Epidemiology
	10:35-10:55	Pathogenesis
	10:55-11:15	Medical treatment
	11:15-11:35	Non-pharmacological treatment for functional dyspepsia
	11:35-11:45	Discussion

Symposium 05 (KSGC) : Hot Era in Upper Gastrointestinal Cancer English

Date / Time	298,
Channel
Speakers	12:25-12:47	Primary 3D culture-based research in upper GI cancer
	12:47-13:09	Current status & future direction of AI in upper GI cancer
	13:09-13:31	Current status & future direction of immunotherapy in upper GI cancer
	13:31-13:53	The Gastric Microbiome in Gastric Cancer

Symposium 09 (KSGC) : Application of Artificial Intelligence on Diagnosis and Management of Colorectal Neoplasia English

Date / Time	298,
Channel
Speakers	14:10-14:32	Artificial intelligence-aided colonoscopy in polyp detection and differentiation
	14:32-14:54	AI assessment for the eligibility for endoscopic resection in patients with early CRC
	14:54-15:16	AI applications in colorectal cancer prognosis and prediction
	15:16-15:38	Digital pathology in CRC diagnosis: Promise and hurdles

Combined Symposium 03 (KSGC+KSG) : Recent Updates of Pancreatic Cancer English

Date / Time	298,
Channel
Speakers	15:55-16:17	Treatment approaches in borderline resectable and locally advanced pancreatic cancer
	16:17-16:39	Are we really making progress in the surgery of pancreatic cancer?
	16:39-17:01	New agent and combination therapy for patients with metastatic pancreatic cancer
	17:01-17:23	Novel Radiotherapy in Pancreatic Cancer

Multidisciplinary Session 01 (KPBA) : New Diagnosis and Treatment Era of Advanced Malignant Hilar Obstruction English

Date / Time	298,
Channel
Speakers	08:30-08:52	Up-to-date of cholangioscopy: From percutaneous to SOC
	08:52-09:14	Optimal endoscopic drainage strategy
	09:14-09:36	Efficacy of RFA and applying strategy
	09:36-09:58	Surgical palliation after neoadjuvant chemotherapy

Basic/Translational Symposium 01 (KPBA) : Advances in Basic and Clinical Research in Pancreatobiliary Cancer English

Date / Time	298,
Channel
Speakers	10:15-10:37	Clinical application of novel biomarker for the diagnosis of pancreatobiliary cancer
	10:37-10:59	Feasibility of developing immune profiles of pancreatitis and pancreatic cancer
	10:59-11:21	NK cell-based immunotherapies in pancreato-biliary cancer
	11:21-11:43	Double spiral microfluidic device for highly elaborated formation of circulating tumor cell-neutrophil clusters through deterministic encapsulation

The 5th Joint Session between KDDW-TDDW-JDDW (Upper GI) : Novel Diagnostic and Therapeutic Approaches to Upper GI Motility Disorders English

Date / Time	298,
Channel
Speakers	08:30-08:50	Usefulness of high-resolution manometry for the management of oropharyngeal dysphagia
	08:50-09:10	Functional dyspepsia -Diagnosis and treatment-
	09:10-09:30	Esophageal mucosal histopathology may help differentiate achalasia from refractory gastroesophageal reflux disease
	09:30-09:40	New parameter for quantifying bolus transit with high-resolution impedance manometry
	09:40-09:50	Assessment of esophagogastric junction in post-POEM reflux esophagitis
	09:50-10:00	Comparison of manometric diagnosis by Chicago classification version 3.0 and 4.0 on esophageal high resolution manometry

The 5th Joint Session between KDDW-TDDW-JDDW (Lower GI) : Optimal Management of IBD in the Biologics Era English

Date / Time	298,
Channel
Speakers	10:15-10:35	Early intervention in IBD: Why and how?
	10:35-10:55	Deep neural network for colonoscopy of ulcerative colitis
	10:55-11:15	Transmural healing: The dream or the ideal to be achieved
	11:15-11:25	Big data research: Progress makes practice in IBD
	11:25-11:35	The role of endoscopy in inflammatory bowel disease
	11:35-11:45	Clostridium innocuum in inflammatory bowel disease

The 5th Joint Session between KDDW-TDDW-JDDW (Pancreatobiliary) : The Strategies for Resectable/borderline-resectable Pancreatic Cancer English

Date / Time	298,
Channel
Speakers	12:25-12:45	Upfront surgery for resectable/borderline-resectable pancreatic cancer
	12:45-13:05	Neoadjuvant therapy for resectable/borderline-resectable pancreatic ductal adenocarcinoma
	13:05-13:25	Should we perform neoadjuvant therapy in resectable pancreatic cancer?
	13:25-13:35	Neoadjuvant chemotherapy for resectable/borderline-resectable pancreatic cancer
	13:35-13:45	The strategies for resectable / borderline-resectable pancreatic cancer
	13:45-13:55	Reshaping resectable/borderline-resectable pancreatic cancer in the era of precision medicine

The 5th Joint Session between KDDW-TDDW-JDDW (Liver) : Strategies for Elimination of Chronic HBV Infection: Current Status and Future Perspectives English

Date / Time	298,
Channel
Speakers	14:10-14:30	Optimize nucleot(s)ide analogues’ to prevent hepatocellular carcinoma in patients with chronic hepatitis B: A lesson from real-world evidence
	14:30-14:50	Current status in hepatitis B management in Japan and future perspectives
	14:50-15:10	Towards Elimination of HBV Infection in Taiwan
	15:10-15:20	Identifying hepatocellular carcinoma risk of untreated chronic hepatitis B for timely antiviral intervention
	15:20-15:30	Role of host immune responses in achieving HBsAg loss
	15:30-15:40	Combined ALT/HBsAg kinetics for re-treatment decision in HBeAg-negative CHB patients with off-Nuc hepatitis flare

Symposium 13 (KSG) : COVID-19 and GI Diseases: How to Manage the Patients English

Date / Time	298,
Channel
Speakers	15:55-16:17	COVID-19 and Endoscopy: Impact and Countermeasures
	16:17-16:39	COVID-19 and IBD
	16:39-17:01	COVID-19 and Cancer

Symposium 06 (KSG) : Clinical Application of Radiomics in Gastroenterology English

Date / Time	298,
Channel
Speakers	12:25-12:47	Radiomics-based clinical model for hepatocellular cancer
	12:47-13:09	Radiomics approaches in gastric cancer and colon cancer
	13:09-13:31	Application of radiomics in inflammatory bowel disease
	13:31-13:53	The application of novel diagnostics and radiomics in the evaluation of pancreatic cystic lesions

Symposium 10 (KASID) : Evolving Considerations in the Treatment of IBD English

Date / Time	298,
Channel
Speakers	14:10-14:30	Application of treat-to-target strategy in clinical practice
	14:30-14:50	Choosing biologic agents beyond conventional therapy: When and What?
	14:50-15:10	Optimal use of therapeutic drug monitoring
	15:10-15:30	Prevention of complications from IBD treatments
	15:30-15:40	Discussion

Basic/Translational Symposium 02 (KASID) : Organoid System as a New Player in Intestinal Diseases: From Bench to Clinical Field English

Date / Time	298,
Channel
Speakers	15:55-16:15	Using organoids to understand colorectal cancer genetic drivers and guide treatment choice
	16:15-16:35	Intestinal organoids as a tool for IBD research
	16:35-16:55	Applications of patient-derived organoids in the management of colorectal cancer
	16:55-17:15	Organoid-based regenerative and precision medicine for IBD
	17:15-17:25	Discussion

Combined Symposium 01 (KSGE+KASID) : Role of Endoscopy in Inflammatory Bowel Disease Korean

Date / Time	298,
Channel
Speakers	08:30-08:52	Can endoscopic disease activity predict the clinical outcome of IBD?
	08:52-09:14	Surveillance colonoscopy for dysplasia: How to optimize it in daily practice
	09:14-09:36	Colitis-associated dysplasia: Resect it or remove the entire colon?
	09:36-09:58	Role and limitation of endoscopic intervention for Crohn's strictures

Combined Symposium 02 (KSGE+KCHUGR) : ESD for EGCa in Challenging Situations Korean

Date / Time	298,
Channel
Speakers	10:15-10:37	Recent guidelines of ESD for EGCa
	10:37-10:59	WHO classifications of gastric cancer-pathology
	10:59-11:21	ESD vs surgery for undifferentiated EGCa
	11:21-11:43	Management after non-curative resection for EGC

Big Data Session 01 (KSG) : Recent Study Using National Health Insurance Research Database in GI Diseases English

Date / Time	298,
Channel
Speakers	15:55-16:17	Chemoprevention of hepatocellular carcinoma: Aspirin and statin
	16:17-16:39	Trends in pancreatitis and pancreatic cancer risk among patients with newly diagnosed type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors
	16:39-17:01	Risk of gastric cancer development: Proton pump inhibitors vs histamine 2 receptor
	17:01-17:23	Severe clinical outcomes of COVID-19 associated with proton pump inhibitors